Flindr Therapeutics

About:

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

Website: https://flindrtx.com/

Twitter/X: immagene1

Top Investors: V-Bio Ventures, Johnson & Johnson Innovation – JJDC, Qbic Fund, BOM, Innovatiefonds Noord-Holland

Description:

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

Total Funding Amount:

20M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Amsterdam, Noord-Holland, The Netherlands

Founded Date:

2020-01-01

Contact Email:

contact(AT)immagene.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-04-24

IPO Status:

Private

Industries: